Olink Proteomics

Proteomics, Unplugged. Powerful. Simplified. Accessible. The power of NGS-based proteomics is here with Reveal. Register on our website to be one of the first to gain access to Olink Reveal:https://hubs.la/Q033W6MP0.

We're #hiring a new Associate Data Scientist in Uppsala, Uppsala County. Apply today or share this post with your network.

While protein biomarker research initially relied on the use of individual markers, these often lack the specificity needed for studying complex diseases driven by multiple pathological processes. Read our latest blog post as we explore how Olink's Proximity Extension Assay has enabled the discovery of protein signatures, providing a more nuanced understanding of human health and disease: https://bit.ly/4bptgJO

We're #hiring a new Development Engineer - Assay Development NGS in Uppsala, Uppsala County. Apply today or share this post with your network.

We're #hiring a new Product Manager - Reveal in European Union. Apply today or share this post with your network.

We're #hiring a new Development Engineer MidPlex in Uppsala, Uppsala County. Apply today or share this post with your network.

Combining proteomics with high-resolution imaging data could be a game-changer in our deeper understanding of disease biology. The UK Biobank Pharma Proteomics Project (UKB-PPP) recently announced the largest proteomics study in history, where they intend to measure over 5,400 proteins in 600,000 samples using Olink® Explore HT. In the clip below, Dr. Whelan describes how the study design of the new phase of the UKB-PPP will provide a new level of granularity in the biological insights obtained, linking not only proteins to disease but also to organ structural changes that are critical to the pathophysiology involved. Watch full version of the Episode 23 of the Proteomics in Proximity podcast (https://hubs.la/Q034spzt0), where Professor Sir Rory Collins (Principal Investigator UK Biobank & University of Oxford) and Dr Chris Whelan (Director, Johnson & Johnson Innovative Medicine) discuss this momentous project and its implications for the development of precision medicine and the future of human healthcare.

We're #hiring a new Development Engineer - MidPlex in Uppsala, Uppsala County. Apply today or share this post with your network.

Ready to advance your protein biomarker research?   Olink Certified Service Providers offer expert support and democratize access to the Olink® PEA technology.  In this video, get to know how the Immune Monitoring and Cancer Omics Laboratories (IMCO) at OHSU Knight Cancer Institute, an Olink Certified Service Provider, can help advance your research, offering support from study design to biological insights.   #Olink #CertifiedServiceProvider #IMCO #translationalresearch

Cardiovascular diseases (CVD) predispose individuals to a higher risk of fragility fractures, but the mechanisms are not well understood. A group from Uppsala University used multiple Olink® Target 96 panels to identify proteins associated with increased risk of fragility-related fractures in two elderly population-based cohorts. Mendelian Randomization (MR) analysis using proteogenomic data from the UK Biobank Pharma Proteomics Project was then performed to examine whether the proteins identified could play causal roles in CVD-associated frailty fractures. Scroll for the article’s key highlights below, and read the original article here: https://hubs.la/Q038Dyd90 #olink